Perrigo Debt to Equity Ratio 2010-2023 | PRGO
Perrigo Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2023-12-31 | $6.04B | $4.77B | 1.27 |
2023-09-30 | $6.02B | $4.74B | 1.27 |
2023-06-30 | $6.12B | $4.85B | 1.26 |
2023-03-31 | $6.12B | $4.83B | 1.27 |
2022-12-31 | $6.18B | $4.84B | 1.28 |
2022-09-30 | $6.08B | $4.60B | 1.32 |
2022-06-30 | $6.07B | $4.85B | 1.25 |
2022-03-31 | $5.29B | $5.11B | 1.04 |
2021-12-31 | $5.27B | $5.15B | 1.02 |
2021-09-30 | $5.73B | $5.18B | 1.11 |
2021-06-30 | $5.72B | $5.51B | 1.04 |
2021-03-31 | $5.77B | $5.56B | 1.04 |
2020-12-31 | $5.83B | $5.66B | 1.03 |
2020-09-30 | $5.76B | $5.82B | 0.99 |
2020-06-30 | $6.22B | $5.91B | 1.05 |
2020-03-31 | $5.61B | $5.79B | 0.97 |
2019-12-31 | $5.50B | $5.80B | 0.95 |
2019-09-30 | $5.55B | $5.76B | 0.96 |
2019-06-30 | $5.70B | $5.73B | 1.00 |
2019-03-31 | $5.42B | $5.70B | 0.95 |
2018-12-31 | $5.32B | $5.67B | 0.94 |
2018-09-30 | $5.28B | $5.66B | 0.93 |
2018-06-30 | $5.33B | $5.90B | 0.90 |
2018-03-31 | $5.43B | $6.21B | 0.88 |
2017-12-31 | $5.46B | $6.17B | 0.89 |
2017-09-30 | $5.80B | $6.04B | 0.96 |
2017-06-30 | $5.71B | $6.08B | 0.94 |
2017-03-31 | $7.91B | $6.07B | 1.30 |
2016-12-31 | $7.91B | $5.96B | 1.33 |
2016-09-30 | $8.41B | $7.48B | 1.12 |
2016-06-30 | $9.24B | $9.05B | 1.02 |
2016-03-31 | $9.77B | $9.73B | 1.01 |
2015-12-31 | $9.24B | $10.11B | 0.92 |
2015-09-30 | $8.97B | $10.73B | 0.84 |
2015-06-30 | $9.06B | $10.66B | 0.85 |
2015-03-31 | $6.60B | $9.59B | 0.69 |
2014-12-31 | $6.75B | $9.72B | 0.69 |
2014-09-30 | $5.06B | $8.72B | 0.58 |
2014-06-30 | $5.19B | $8.69B | 0.60 |
2014-03-31 | $5.18B | $8.56B | 0.61 |
2013-12-31 | $5.21B | $8.50B | 0.61 |
2013-09-30 | $3.04B | $2.47B | 1.23 |
2013-06-30 | $3.02B | $2.33B | 1.29 |
2013-03-31 | $2.27B | $2.23B | 1.02 |
2012-12-31 | $2.19B | $2.11B | 1.04 |
2012-09-30 | $2.15B | $1.97B | 1.10 |
2012-06-30 | $2.17B | $1.85B | 1.17 |
2012-03-31 | $2.27B | $1.77B | 1.28 |
2011-12-31 | $2.31B | $1.63B | 1.42 |
2011-09-30 | $1.97B | $1.54B | 1.28 |
2011-06-30 | $1.66B | $1.53B | 1.08 |
2011-03-31 | $1.61B | $1.43B | 1.13 |
2010-12-31 | $1.63B | $1.31B | 1.24 |
2010-09-30 | $1.57B | $1.21B | 1.30 |
2010-06-30 | $2.02B | $1.09B | 1.84 |
2010-03-31 | $1.43B | $1.06B | 1.35 |
2009-12-31 | $1.47B | $0.99B | 1.49 |
2009-09-30 | $1.44B | $0.96B | 1.50 |
2009-06-30 | $1.61B | $0.92B | 1.75 |
2009-03-31 | $1.53B | $0.84B | 1.82 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.057B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.663B | 23.98 |
Stryker (SYK) | United States | $124.585B | 30.89 |
Medtronic (MDT) | Ireland | $105.150B | 14.89 |
Boston Scientific (BSX) | United States | $98.912B | 32.89 |
EssilorLuxottica (ESLOY) | France | $98.803B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.442B | 0.00 |
Haleon (HLN) | United Kingdom | $37.123B | 29.04 |
ResMed (RMD) | United States | $26.124B | 26.12 |
Terumo (TRUMY) | Japan | $24.607B | 34.75 |
Zimmer Biomet Holdings (ZBH) | United States | $24.518B | 15.78 |
Baxter (BAX) | United States | $20.135B | 14.69 |
Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
Insulet (PODD) | United States | $11.535B | 60.56 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.496B | 0.00 |
Demant (WILYY) | Denmark | $9.782B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.014B | 23.88 |
BellRing Brands (BRBR) | United States | $7.103B | 38.19 |
Lantheus Holdings (LNTH) | United States | $4.273B | 11.03 |
Haemonetics (HAE) | United States | $4.239B | 21.68 |
GN Store Nord (GNNDY) | Denmark | $3.581B | 23.19 |
Envista Holdings (NVST) | United States | $3.394B | 12.91 |
Prestige Consumer Healthcare (PBH) | United States | $3.394B | 16.05 |
Green Thumb Industries (GTBIF) | United States | $2.720B | 86.20 |
Neogen (NEOG) | United States | $2.584B | 24.85 |
QuidelOrtho (QDEL) | United States | $2.559B | 9.29 |
ICU Medical (ICUI) | United States | $2.361B | 17.62 |
TG Therapeutics (TGTX) | United States | $2.160B | 699.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.913B | 0.00 |
Owens & Minor (OMI) | United States | $1.843B | 17.69 |
Verano Holdings (VRNOF) | United States | $1.841B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.654B | 0.00 |
National Vision Holdings (EYE) | United States | $1.466B | 45.66 |
InMode (INMD) | Israel | $1.456B | 7.54 |
LeMaitre Vascular (LMAT) | United States | $1.406B | 46.38 |
AdaptHealth (AHCO) | United States | $1.244B | 9.36 |
Warby Parker (WRBY) | United States | $1.169B | 0.00 |
AtriCure (ATRC) | United States | $1.131B | 0.00 |
MacroGenics (MGNX) | United States | $1.005B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
Canopy Growth (CGC) | Canada | $0.713B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.687B | 14.84 |
Evolus (EOLS) | United States | $0.670B | 0.00 |
Jin Medical (ZJYL) | China | $0.617B | 0.00 |
Quanterix (QTRX) | United States | $0.604B | 0.00 |
Valneva SE (VALN) | France | $0.565B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.528B | 11.44 |
TerrAscend (TSNDF) | Canada | $0.507B | 0.00 |
PetIQ (PETQ) | United States | $0.472B | 17.61 |
ZimVie (ZIMV) | United States | $0.427B | 26.13 |
Biote (BTMD) | United States | $0.405B | 3.86 |
OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
Surmodics (SRDX) | United States | $0.376B | 40.60 |
Zynex (ZYXI) | United States | $0.368B | 42.41 |
Aurora Cannabis (ACB) | Canada | $0.356B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.302B | 30.00 |
Cerus (CERS) | United States | $0.297B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.241B | 14.71 |
Veru (VERU) | United States | $0.208B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Omeros (OMER) | United States | $0.186B | 0.00 |
High Tide (HITI) | Canada | $0.175B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.148B | 0.00 |
FitLife Brands (FTLF) | United States | $0.134B | 21.55 |
Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
InterCure (INCR) | Israel | $0.118B | 19.92 |
Fonar (FONR) | United States | $0.106B | 9.14 |
MariMed (MRMD) | United States | $0.104B | 0.00 |
Safety Shot (SHOT) | United States | $0.099B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.098B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.083B | 0.00 |
Brainsway (BWAY) | Israel | $0.080B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
Apyx Medical (APYX) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 14.04 |
Exagen (XGN) | United States | $0.025B | 0.00 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
GlucoTrack (GCTK) | United States | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 73.18 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |